Phase 4 Psoriatic Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 12 and 59 years old
- You are male or female
- You have been diagnosed with an autoimmune rheumatic disease (such as rheumatoid arthritis, lupus, juvenile idiopathic arthritis, Sjögren's syndrome, or vasculitis) based on recognised medical standards
- Your autoimmune condition has been stable for at least 3 months
- You are either taking no immunosuppressive (immune-lowering) medications, or only low-level ones such as hydroxychloroquine, sulfasalazine, low-dose prednisone, methotrexate, leflunomide, azathioprine, or certain combinations of these (confirm with trial site for exact doses)
- You are a healthy volunteer matched by age and sex to a patient in the trial, with no history of autoimmune or long-term infectious diseases and not taking immune-lowering medications
- You are willing and able to follow the study procedures and attend follow-up visits
- If you are a woman who could become pregnant, you have a negative pregnancy test at the start of the study
- If you are a woman who could become pregnant, you agree to use effective contraception for at least 90 days after receiving the vaccination
Who may not be able to join:
- You have previously received any dengue vaccine
- You received a live attenuated vaccine (such as certain flu or MMR vaccines) within the past 4 weeks
- You received an inactivated vaccine within the past 2 weeks
- You have a known allergy to any ingredient in the study vaccine
- You have had a fever (38°C / 100°F or higher) in the 72 hours before vaccination
- You have a history of immune deficiency conditions
- You have had your spleen removed or have a non-functioning spleen
- You have a history of cancer
- You have a history of HIV infection
- You have a primary (inherited) immune deficiency condition
- You take immune-suppressing medications due to an organ transplant
- You have an ongoing, uncontrolled long-term health condition such as heart failure, kidney failure, liver problems, or diabetes
- You are currently hospitalised or have an acute illness at the time of screening
- You have received a blood transfusion within the past 3 months
- You are currently pregnant or breastfeeding
- You are planning to become pregnant within 90 days after vaccination
- You have taken part in another clinical trial within the past 30 days
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +55 11 2661-8806
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Seroconversion Rate After Vaccination; Frequency and Intensity of Common Adverse Events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.